A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma

NCT04007198 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: EQ001
DRUG: EQ001 Placebo

Sponsor

Equillium

Collaborators

[object Object]
[object Object]